Prediction of Risk of Disease Recurrence by Genome-Wide cDNA Microarray Analysis in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Imatinib-Combined Chemotherapy

International Journal of Oncology - Greece
doi 10.3892/ijo.31.2.313
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Pcn137 - The Economic Evaluation of Imatinib Combined With Chemotherapy for Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor

Cureus
2019English

A Pathway-Based Gene Signature Correlates With Therapeutic Response in Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Modern Pathology
Forensic MedicinePathology
2010English

Lymphoblasts Expressing Surface IgM in the Absence of Kappa and Lambda in Philadelphia Positive Acute Lymphoblastic Leukemia: Philadelphia Chromosome Positive Transitional Pre-B Acute Lymphoblastic Leukemia

Clinical Case Reports and Reviews
2018English

Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Drugs and Therapy Studies
2012English

Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults

American Journal of Hematology
Hematology
2017English

Efficacy and Safety of Imatinib Mesylate (Glivec™) in Combination With Interferon-Α (IFN-α) in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay

Leukemia Research
Cancer ResearchOncologyHematology
2011English

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy